December, 2019 - Rapha Capital Management, LLC

Kevin Slawin In Portfolio

ControlRad adds five people to leadership team

ControlRad announced today that it made several additions to its leadership team, naming a new chief financial officer, VP of U.S….

Read More

Kevin Slawin In NexImmune, Inc., Portfolio

NexImmune Appoints Sol Barer as Chairman of the Board of Directors

NexImmune Inc. NexImmune Appoints Sol Barer as Chairman of the Board of Directors December 16, 2019

Read More

Kevin Slawin In Portfolio, PrintBio, Inc.

3DBio Therapeutics Receives FDA Rare Pediatric Disease Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients

NEW YORK, Dec. 6, 2019 /PRNewswire/ — 3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today…

Read More

© 2026 Rapha Capital Management, LLC. All rights reserved. Disclaimer | Privacy Policy